Executive Summary

MY healthcare-travel revenue 2025
3.34RM bn
↑ from RM2.72 bn in 2024
Malay Mail 2026
Inbound healthcare travellers 2025
1.84mn
↑ 15% from 1.6 mn in 2024
MHTC 2025
Penang share of foreign patients
527k
↑ 25.9% YoY, RM1.14 bn
Penang Health 2026
2030 national revenue target
12RM bn
~3.6x the 2025 base
MHTC 2025

Where the market stands

Malaysia drew 1.84 million healthcare travellers in 2025, generating RM3.34 billion [Malay Mail 2026], up from RM2.72 billion on 1.6 million arrivals in 2024 [MHTC 2025]. Indonesia alone supplies roughly 65% of inbound volume [MIDA 2024]; China, India, Singapore and the UK round out an 80%-of-volume top five [Malay Mail 2026]. The council has declared 2026 the Malaysia Year of Medical Tourism and set a RM12 billion revenue goal for 2030 [MHTC 2025].

The competitive reality

Thailand remains the regional reference brand, drawing 1.4 million-plus international patients across a far larger medical-and-wellness economy [GM Insights 2024]. Malaysia competes on a sharper cost line — IVF near USD 3,000-4,000 a cycle against USD 8,000-12,000 in Thailand [BestClinicAbroad 2025] — plus English-fluent specialists and JCI-accredited care. The risk is a thinning specialist pipeline at 2.3 doctors per 1,000 [FocusMalaysia 2025].

Malaysia healthcare-travel revenue
RM bn · 2022-2030F
RM BN
0 3 6 9 12 2.25 2022 2.25 2023 2.72 2024 3.34 2025 ~4.2 2026F 12.0 2030F
SOURCE: MHTC, MALAY MAIL, KIRA TRIANGULATION · KIRA RESEARCH 2026
MHTC 2025 = Malaysia Healthcare Travel Council disclosures 2025 · Malay Mail 2026 = Malay Mail healthcare-travel coverage Apr 2026 · MIDA 2024 = Malaysian Investment Development Authority 2024 · GM Insights 2024 = Global Market Insights Thailand medical & wellness 2024 · BestClinicAbroad 2025 = Best Clinic Abroad cost survey 2025 · FocusMalaysia 2025 = Focus Malaysia workforce reporting 2025 · Kira estimates = KIRA in-house analyst triangulation

A market that has tripled its revenue base since the rebound

Healthcare-travel revenue climbed from a pandemic trough to RM3.34 billion in 2025, a 21%-plus annual step in the latest year. Volume growth is real, but revenue per traveller — not headcount alone — now carries the trajectory toward the 2030 goal.

Revenue has outpaced arrivals

Arrivals rose 14% to 1.6 million in 2024 while revenue grew 21% to RM2.72 billion [MHTC 2025] — evidence that average treatment value, not just footfall, is lifting. In 2025 the council reported 1.84 million travellers and RM3.34 billion [Malay Mail 2026]. Non-medical spend adds a further layer, averaging roughly RM2,680 per visitor [MHTC 2025].

The 2030 gap is steep but coordinated

Reaching RM12 billion by 2030 [MHTC 2025] implies a compound pace near 29% a year from the 2025 base [Kira estimates] — well above the recent low-20s trend. Closing it requires higher-acuity case mix and capacity additions, not Indonesian volume alone. KIRA models a base case nearer RM8-9 billion absent a step-change in complex-care throughput [Kira estimates].

Travellers vs revenue
arrivals (mn) & revenue (RM bn) · 2023-2025
INDEX
2023 1.40 2.25 2024 1.60 2.72 2025 1.84 3.34 Arrivals (mn) Revenue (RM bn)
SOURCE: MHTC, MALAY MAIL · KIRA RESEARCH 2026
MHTC 2025 = Malaysia Healthcare Travel Council disclosures 2025 · Malay Mail 2026 = Malay Mail healthcare-travel coverage Apr 2026 · Kira estimates = KIRA in-house analyst triangulation